Seagen

SGEN

Rank 611

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Address 21823 30TH DRIVE SE, SUITE, BOTHELL, WA, US

Seagen - Key figures

Market cap 26.98 Billion

Revenue 1.67 Billion

Profit 34.13 Million

P/E Ratio No information

P/s Ratio 16.16

Seagen Inc., a biotechnology company, develops and markets cancer treatment therapies in the United States and internationally.

The company is headquartered in Bothell, Washington.